| Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation S Fulsundar, K Harms, GE Flaten, PJ Johnsen, BA Chopade, KM Nielsen Applied and environmental microbiology 80 (11), 3469-3483, 2014 | 242 | 2014 |
| In vitro skin models as a tool in optimization of drug formulation GE Flaten, Z Palac, A Engesland, J Filipović-Grčić, Ž Vanić, ... European journal of pharmaceutical sciences 75, 10-24, 2015 | 230 | 2015 |
| Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion GE Flaten, AB Dhanikula, K Luthman, M Brandl European journal of pharmaceutical sciences 27 (1), 80-90, 2006 | 224 | 2006 |
| Drug permeability profiling using cell-free permeation tools: Overview and applications P Berben, A Bauer-Brandl, M Brandl, B Faller, GE Flaten, AC Jacobsen, ... European Journal of Pharmaceutical Sciences 119, 219-233, 2018 | 189 | 2018 |
| A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption J Isaksson, BO Brandsdal, M Engqvist, GE Flaten, JSM Svendsen, ... Journal of medicinal chemistry 54 (16), 5786-5795, 2011 | 180 | 2011 |
| Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network Z Vinarov, B Abrahamsson, P Artursson, H Batchelor, P Berben, ... Advanced Drug Delivery Reviews 171, 289-331, 2021 | 98 | 2021 |
| Drug permeability across a phospholipid vesicle-based barrier: 2. Characterization of barrier structure, storage stability and stability towards pH changes GE Flaten, H Bunjes, K Luthman, M Brandl European journal of pharmaceutical sciences 28 (4), 336-343, 2006 | 87 | 2006 |
| Drug permeability across a phospholipid vesicle-based barrier: 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability GE Flaten, K Luthman, T Vasskog, M Brandl European journal of pharmaceutical sciences 34 (2-3), 173-180, 2008 | 65 | 2008 |
| In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants SM Fischer, GE Flaten, E Hagesæther, G Fricker, M Brandl Journal of Pharmacy and Pharmacology 63 (8), 1022-1030, 2011 | 64 | 2011 |
| Chitosan in mucoadhesive drug delivery: Focus on local vaginal therapy T Andersen, S Bleher, GE Flaten, I Tho, S Mattsson, N Škalko-Basnet Marine drugs 13 (1), 222-236, 2015 | 63 | 2015 |
| Synthesis of Cationic Antimicrobial β2,2-Amino Acid Derivatives with Potential for Oral Administration T Hansen, D Ausbacher, GE Flaten, M Havelkova, MB Strøm Journal of medicinal chemistry 54 (3), 858-868, 2011 | 63 | 2011 |
| Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development Z Palac, A Engesland, GE Flaten, N Škalko-Basnet, J Filipović-Grčić, ... Journal of liposome research 24 (4), 313-322, 2014 | 61 | 2014 |
| Altered activity and physicochemical properties of short cationic antimicrobial peptides by incorporation of arginine analogues J Svenson, R Karstad, GE Flaten, BO Brandsdal, M Brandl, JS Svendsen Molecular pharmaceutics 6 (3), 996-1005, 2009 | 57 | 2009 |
| Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug–membrane interactions and the effect of agitation on the barrier integrity and on the … GE Flaten, M Skar, K Luthman, M Brandl european journal of pharmaceutical sciences 30 (3-4), 324-332, 2007 | 56 | 2007 |
| New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier A Engesland, M Skar, T Hansen, N Škalko-Basnet, GE Flaten Journal of Pharmaceutical Sciences 102 (5), 1588-1600, 2013 | 53 | 2013 |
| In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier J Kanzer, I Tho, GE Flaten, M Mägerlein, P Hölig, G Fricker, M Brandl Journal of Pharmacy and Pharmacology 62 (11), 1591-1598, 2010 | 51 | 2010 |
| Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes T Andersen, E Mishchenko, GE Flaten, JUE Sollid, S Mattsson, I Tho, ... Marine Drugs 15 (3), 64, 2017 | 48 | 2017 |
| A method to determine the incorporation capacity of camptothecin in liposomes AM Sætern, GE Flaten, M Brandl Aaps Pharmscitech 5, 30-37, 2004 | 48 | 2004 |
| Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration A Engesland, N Škalko-Basnet, GE Flaten Journal of Pharmaceutical Sciences 104 (3), 1119-1127, 2015 | 44 | 2015 |
| Deformable liposomes for skin therapy with human epidermal growth factor: The effect of liposomal surface charge S Ternullo, P Basnet, AM Holsæter, GE Flaten, L de Weerd, ... European Journal of Pharmaceutical Sciences 125, 163-171, 2018 | 42 | 2018 |
